Givat Shmuel, Israel – May 30, 2013 – Cimatron Limited (NASDAQ: CIMT) today announced that its integrated CAD/CAM software, CimatronE, will be powering the Mitsubishi Machine Tools' live milling demonstration at the Feimafe trade show in São Paulo, Brazil, June 3-8, 2013.
"Cimatron is investing more than ever before in the Brazilian manufacturing field, assisting local mold and die makers in significantly boosting their productivity," said Alexandre Censi, Cimatron's country manager for Brazil.
"The five local resellers of our integrated CAD/CAM solution, CimatronE, offer an exceptionally high level of localized support to ensure that Brazilian mold and die shops benefit from the full range of CimatronE's dedicated mold and die design and NC programming capabilities. With offices across the main industrial regions, our resellers provide tailored training and technical support in line with shops' specific needs."
The live milling demonstration at Feimafe powered by CimatronE will be held at the booth of Mitsubishi Machine Tools (#J14). The parts to be milled with the DEV1000 and TV 500 machines include a blow mold for the base of a plastic soda bottle, employing a range of capabilities that enable the creation of an accurate, smooth toolpath, mirror-finish part quality, and the use of short tools for safe tooling with minimal vibration.
CimatronE functionality will also be showcased at Feimafe at the Cimatron booth (#P71). Representatives from Brazilian resellers Autoflow, Cimacad, Delcon and Fitso will be on hand to demonstrate the new and enhanced CAD and CAM modules in the latest version of the software, CimatronE 11.
More information on CimatronE 11 can be found at https://www.3dsystems.com/software/cimatron
For more information on Cimatron's activities in Brazil, contact:
Mr. Alexandre Censi
With more than 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron's shares are publicly traded on the NASDAQ under the symbol CIMT. For more information, visit http://www.cimatron.com
This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward-looking statements include, but are not limited to currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or the combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.